Vista Current Coverage

All Atossa Genetics, Inc. Articles

Keeps On Keepin’ On

The kids are back in school, and Congress and the Federal Reserve are back in session. The big news in September had to do with the Federal Reserve’s unwinding of its post-financial crisis monetary policy. At a two-day meeting this month, Fed members unanimously agreed...

“Wild & Crazy?” Or “Calm & Sane?”

No we are not suggesting that the woman pictured is “Wild & Crazy”  or  for that matter “Calm & Sane”, but we are confirming that Vista Partners Weekly Market Update for Week Ending September 2017 called “Wild & Crazy” is available. It includes a quick...

Sarepta Announces Positive Results…Shares Rise

Sarepta Therapeutics, Inc. (SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic medicines to treat rare neuromuscular diseases, today announced muscle biopsy results from its 4053-101 study, a Phase 1/2 first-in-human study conducted in Europe to assess the safety, tolerability,...

“Meeting or Exceeding Expections”

Vista Partners (“Vista”) has published its FREE Macroeconomic & Investment Monthly Newsletter for the month of August. Each monthly newsletter from Vista contains macroeconomic thoughts, investment considerations with regard to Biotechnology, Cloud Services, Energy, Fintech, Healthcare Insurance, Manufacturing, SaaS, & Technology, monthly highlights from select...